About
Device for restless Leg
Areas of Focus
Categories
Uncategorized Medical DeviceBiotech
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
7
As Collaborator
1
Total Enrollment
1,153
By Phase
NA: 6
By Status
COMPLETED: 6ACTIVE_NOT_RECRUITING: 2
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06866132Lead Sponsor
Response to an Investigational Device in Patients With Restless Legs Syndrome
NAActive, not recruiting
20 participants
Started: Mar 11, 2025 · Completed: Sep 30, 2025
NCT06076499Lead Sponsor
A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS
N/AActive, not recruiting
325 participants
Started: Nov 15, 2023 · Completed: Dec 31, 2026
NCT05763225Collaborator
Validation of Patient E-tool to Measure Systemic Lupus Activity
N/ACompleted
450 participants
Started: Feb 9, 2023 · Completed: Jun 15, 2024
NCT05214963Lead Sponsor
Noninvasive Peripheral Nerve Stimulation for Medication-Naive and Medication-Refractory RLS
NACompleted
58 participants
Started: Mar 8, 2022 · Completed: Oct 24, 2023
NCT05196828Lead Sponsor
Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS
NACompleted
103 participants
Started: Dec 20, 2021 · Completed: Nov 18, 2022
Funding History (1)
D
Jan 15, 2021
Locations (1)
Headquarters
Pleasanton, CA, United States
Map
Loading map...